Skip Nav Destination
Close
Article navigation
Meeting Abstracts|
September 1979
AUTONOMIC/NEUROMUSCULAR DOSE-RATIOS AND HEMODYNAMIC EFFECTS OF BW785U, A SHORT-ACTING NONDEPOLARIZING ESTER NEUROMUSCULAR BLOCKING AGENT
Department of Pharmacology, Wellcome Research Laboratories, Burroughs Wellcome Company, Research Triangle Park, North Carolina, and Anesthesia Laboratories, Harvard Medical School at Massachusetts General Hospital, Boston, Massachusetts
Anesthesiology September 1979, Vol. 51, S279.
Citation
William B. Wastila, John J. Savarese; AUTONOMIC/NEUROMUSCULAR DOSE-RATIOS AND HEMODYNAMIC EFFECTS OF BW785U, A SHORT-ACTING NONDEPOLARIZING ESTER NEUROMUSCULAR BLOCKING AGENT. Anesthesiology 1979; 51:S279 doi: https://doi.org/10.1097/00000542-197909001-00278
Download citation file:
Close
8
Views
0
Citations
Citing articles via
Most Viewed
Related Articles
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine—Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat
Anesthesiology (October 2016)
Modifying Methoxycarbonyl Etomidate Inter-Ester Spacer Optimizes In Vitro Metabolic Stability and In Vivo Hypnotic Potency and Duration of Action
Anesthesiology (November 2012)
Insights into the Chemical Discovery of Remifentanil
Anesthesiology (May 2020)
Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine
Anesthesiology (November 2018)
Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia
Anesthesiology (October 2016)
